News

  • 19 October 2018

    Deals this week: Eisai Pharmaceutical, Abbvie, Otsuka

    Eisai Pharmaceutical has signed an agreement with Eurofarma Laboratorios for the marketing and distribution of its anti-obesity drug lorcaserin hydrochloride (marketed as BELVIQ in the US) in 17 countries in...